Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Stocker

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Journal for Immunotherapy of Cancer|July 15, 2025
ANV600 is a novel PD-1 targeted IL-2Rβγ agonist that selectively expands tumor antigen-specific T cells and potentiates PD-1 checkpoint inhibitor therapyPatrizia Murer, Laetitia Petersen, Nicole Egli, et al.
Science (New York, N.Y.)|July 25, 2020
An evolution-based model for designing chorismate mutase enzymesWilliam P Russ, Matteo Figliuzzi, Christian Stocker, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|October 25, 2023
Perioperative dexmedetomidine compared to midazolam in children undergoing open-heart surgery: A pilot randomised controlled trialDebbie A Long, Kristen S Gibbons, Christian Stocker, et al.
Journal of the American Heart Association|May 2, 2019
RACHS - ANZ : A Modified Risk Adjustment in Congenital Heart Surgery Model for Outcome Surveillance in Australia and New ZealandBrent McSharry, Lahn Straney, Janet Alexander, et al.
BMJ Open|July 15, 2022
Effectiveness-implementation hybrid-2 randomised trial of a collaborative Shared Care Model for Detecting Neurodevelopmental Impairments after Critical Illness in Young Children (DAISY): pilot study protocolDebbie Long, Kristen Gibbons, Belinda Dow, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Journal for Immunotherapy of Cancer|July 15, 2025
ANV600 is a novel PD-1 targeted IL-2Rβγ agonist that selectively expands tumor antigen-specific T cells and potentiates PD-1 checkpoint inhibitor therapyPatrizia Murer, Laetitia Petersen, Nicole Egli, et al.
Science (New York, N.Y.)|July 25, 2020
An evolution-based model for designing chorismate mutase enzymesWilliam P Russ, Matteo Figliuzzi, Christian Stocker, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|October 25, 2023
Perioperative dexmedetomidine compared to midazolam in children undergoing open-heart surgery: A pilot randomised controlled trialDebbie A Long, Kristen S Gibbons, Christian Stocker, et al.
Journal of the American Heart Association|May 2, 2019
RACHS - ANZ : A Modified Risk Adjustment in Congenital Heart Surgery Model for Outcome Surveillance in Australia and New ZealandBrent McSharry, Lahn Straney, Janet Alexander, et al.
BMJ Open|July 15, 2022
Effectiveness-implementation hybrid-2 randomised trial of a collaborative Shared Care Model for Detecting Neurodevelopmental Impairments after Critical Illness in Young Children (DAISY): pilot study protocolDebbie Long, Kristen Gibbons, Belinda Dow, et al.
Pageof 3